Laboratory Services News Effective Monday, December 6, 2021, Nationwide Children’s Laboratory Services will change notification of Laboratory Courtesy results to community physicians. For more information, please click here. Testing Updates On May 16, 2022, Group A Strep rRNA GenProb (test code GASDRP) will be retired and replaced with Group A Strep, Molecular (test code GASM). The new GASM test will require the same COPAN/BBL dual/single culture swab in liquid Stuart’s transport media. Only throat swabs are acceptable. For more information, click here. On March, 14, 2022, the Institute for Genomic Medicine (IGM) Clinical Laboratory will be offering a new test called Next Generation Sequencing (NGS) Neuroblastoma Panel. Please note, this test will be replacing the ALK Targeted Sequencing Assay (test code ALK). For more information, click here. On March 7, 2022, the NCH Institute for Genomic Medicine (IGM) Clinical Laboratory will start offering a new test called Spinal Muscular Atrophy (SMA) Dosage Analysis. Please note, this test will be replacing the ALK Targeted Sequencing Assay (test code ALK). For more information, click here. On February 23, 2022, Quantitative Amino Acid testing for CSF (QAAC), Serum/Plasma (QAAS),Urine (QAAUP), and Maple Syrup Disease Monitor (MSUD) will be updated to a new methodology of Liquid Chromatography – Tandem Mass Spectrometry (LC-MS/MS) from High Performance Liquid Chromatography (HPLC). A cross reference of old to new test codes are shown below:
New Reference Ranges December 6, 2022 HVA and VMA Reference Ranges June 27. 2022 CSF Cell Count Reference Ranges May 16, 2022 Lead Testing-Whole Blood and Filter Card February 23, 2022: Plasma Amino Acids Urine Amino Acids CSF Amino Acids Osmolality Serum and Plasma Sexually Transmitted Infection Testing Resources Nationwide Children’s Laboratory Services provides resources for health care professionals, including a Sexually Transmitted Infections Practice Tool. Visit Clinical Tools for a complete list. Included in the current STI Practice Tool are recommendations from the Centers for Disease Control and Prevention (CDC) regarding “opt-out” testing policies. According to CDC recommendations, providers might consider opt-out chlamydia and gonorrhea screening (i.e., the patient is notified that testing will be performed unless the patient declines, regardless of reported sexual activity) for adolescent and young adult females during clinical encounters. Cost-effectiveness analyses indicate that opt-out chlamydia screening among adolescent and young adult females might substantially increase screening, be cost saving and identify infections among patients who do not disclose sexual behavior. Nationwide Children’s has provided sample opt-out letters that providers may download and customize for patient/parent communication: Patient Letter (Customizable) Download:
English Spanish
Parent Letter (Customizable) Download:
English Spanish
Laboratory Services News Effective Monday, December 6, 2021, Nationwide Children’s Laboratory Services will change notification of Laboratory Courtesy results to community physicians. For more information, please click here. Testing Updates On May 16, 2022, Group A Strep rRNA GenProb (test code GASDRP) will be retired and replaced with Group A Strep, Molecular (test code GASM). The new GASM test will require the same COPAN/BBL dual/single culture swab in liquid Stuart’s transport media. Only throat swabs are acceptable. For more information, click here. On March, 14, 2022, the Institute for Genomic Medicine (IGM) Clinical Laboratory will be offering a new test called Next Generation Sequencing (NGS) Neuroblastoma Panel. Please note, this test will be replacing the ALK Targeted Sequencing Assay (test code ALK). For more information, click here. On March 7, 2022, the NCH Institute for Genomic Medicine (IGM) Clinical Laboratory will start offering a new test called Spinal Muscular Atrophy (SMA) Dosage Analysis. Please note, this test will be replacing the ALK Targeted Sequencing Assay (test code ALK). For more information, click here. On February 23, 2022, Quantitative Amino Acid testing for CSF (QAAC), Serum/Plasma (QAAS),Urine (QAAUP), and Maple Syrup Disease Monitor (MSUD) will be updated to a new methodology of Liquid Chromatography – Tandem Mass Spectrometry (LC-MS/MS) from High Performance Liquid Chromatography (HPLC). A cross reference of old to new test codes are shown below:
New Reference Ranges December 6, 2022 HVA and VMA Reference Ranges June 27. 2022 CSF Cell Count Reference Ranges May 16, 2022 Lead Testing-Whole Blood and Filter Card February 23, 2022: Plasma Amino Acids Urine Amino Acids CSF Amino Acids Osmolality Serum and Plasma Sexually Transmitted Infection Testing Resources Nationwide Children’s Laboratory Services provides resources for health care professionals, including a Sexually Transmitted Infections Practice Tool. Visit Clinical Tools for a complete list. Included in the current STI Practice Tool are recommendations from the Centers for Disease Control and Prevention (CDC) regarding “opt-out” testing policies. According to CDC recommendations, providers might consider opt-out chlamydia and gonorrhea screening (i.e., the patient is notified that testing will be performed unless the patient declines, regardless of reported sexual activity) for adolescent and young adult females during clinical encounters. Cost-effectiveness analyses indicate that opt-out chlamydia screening among adolescent and young adult females might substantially increase screening, be cost saving and identify infections among patients who do not disclose sexual behavior. Nationwide Children’s has provided sample opt-out letters that providers may download and customize for patient/parent communication: Patient Letter (Customizable) Download:
English Spanish
Parent Letter (Customizable) Download:
English Spanish
Laboratory Services News Effective Monday, December 6, 2021, Nationwide Children’s Laboratory Services will change notification of Laboratory Courtesy results to community physicians. For more information, please click here. Testing Updates On May 16, 2022, Group A Strep rRNA GenProb (test code GASDRP) will be retired and replaced with Group A Strep, Molecular (test code GASM). The new GASM test will require the same COPAN/BBL dual/single culture swab in liquid Stuart’s transport media. Only throat swabs are acceptable. For more information, click here. On March, 14, 2022, the Institute for Genomic Medicine (IGM) Clinical Laboratory will be offering a new test called Next Generation Sequencing (NGS) Neuroblastoma Panel. Please note, this test will be replacing the ALK Targeted Sequencing Assay (test code ALK). For more information, click here. On March 7, 2022, the NCH Institute for Genomic Medicine (IGM) Clinical Laboratory will start offering a new test called Spinal Muscular Atrophy (SMA) Dosage Analysis. Please note, this test will be replacing the ALK Targeted Sequencing Assay (test code ALK). For more information, click here. On February 23, 2022, Quantitative Amino Acid testing for CSF (QAAC), Serum/Plasma (QAAS),Urine (QAAUP), and Maple Syrup Disease Monitor (MSUD) will be updated to a new methodology of Liquid Chromatography – Tandem Mass Spectrometry (LC-MS/MS) from High Performance Liquid Chromatography (HPLC). A cross reference of old to new test codes are shown below:
New Reference Ranges December 6, 2022 HVA and VMA Reference Ranges June 27. 2022 CSF Cell Count Reference Ranges May 16, 2022 Lead Testing-Whole Blood and Filter Card February 23, 2022: Plasma Amino Acids Urine Amino Acids CSF Amino Acids Osmolality Serum and Plasma Sexually Transmitted Infection Testing Resources Nationwide Children’s Laboratory Services provides resources for health care professionals, including a Sexually Transmitted Infections Practice Tool. Visit Clinical Tools for a complete list. Included in the current STI Practice Tool are recommendations from the Centers for Disease Control and Prevention (CDC) regarding “opt-out” testing policies. According to CDC recommendations, providers might consider opt-out chlamydia and gonorrhea screening (i.e., the patient is notified that testing will be performed unless the patient declines, regardless of reported sexual activity) for adolescent and young adult females during clinical encounters. Cost-effectiveness analyses indicate that opt-out chlamydia screening among adolescent and young adult females might substantially increase screening, be cost saving and identify infections among patients who do not disclose sexual behavior. Nationwide Children’s has provided sample opt-out letters that providers may download and customize for patient/parent communication: Patient Letter (Customizable) Download:
English Spanish
Parent Letter (Customizable) Download:
English Spanish
Laboratory Services News
Effective Monday, December 6, 2021, Nationwide Children’s Laboratory Services will change notification of Laboratory Courtesy results to community physicians. For more information, please click here.
Testing Updates
On May 16, 2022, Group A Strep rRNA GenProb (test code GASDRP) will be retired and replaced with Group A Strep, Molecular (test code GASM). The new GASM test will require the same COPAN/BBL dual/single culture swab in liquid Stuart’s transport media. Only throat swabs are acceptable. For more information, click here.
On March, 14, 2022, the Institute for Genomic Medicine (IGM) Clinical Laboratory will be offering a new test called Next Generation Sequencing (NGS) Neuroblastoma Panel. Please note, this test will be replacing the ALK Targeted Sequencing Assay (test code ALK). For more information, click here.
On March 7, 2022, the NCH Institute for Genomic Medicine (IGM) Clinical Laboratory will start offering a new test called Spinal Muscular Atrophy (SMA) Dosage Analysis. Please note, this test will be replacing the ALK Targeted Sequencing Assay (test code ALK). For more information, click here.
On February 23, 2022, Quantitative Amino Acid testing for CSF (QAAC), Serum/Plasma (QAAS),Urine (QAAUP), and Maple Syrup Disease Monitor (MSUD) will be updated to a new methodology of Liquid Chromatography – Tandem Mass Spectrometry (LC-MS/MS) from High Performance Liquid Chromatography (HPLC). A cross reference of old to new test codes are shown below:
New Reference Ranges
December 6, 2022
HVA and VMA Reference Ranges
June 27. 2022
CSF Cell Count Reference Ranges
May 16, 2022
Lead Testing-Whole Blood and Filter Card
February 23, 2022:
Plasma Amino Acids
Urine Amino Acids
CSF Amino Acids
Osmolality Serum and Plasma
Sexually Transmitted Infection Testing Resources
Nationwide Children’s Laboratory Services provides resources for health care professionals, including a Sexually Transmitted Infections Practice Tool. Visit Clinical Tools for a complete list.
Included in the current STI Practice Tool are recommendations from the Centers for Disease Control and Prevention (CDC) regarding “opt-out” testing policies.
According to CDC recommendations, providers might consider opt-out chlamydia and gonorrhea screening (i.e., the patient is notified that testing will be performed unless the patient declines, regardless of reported sexual activity) for adolescent and young adult females during clinical encounters. Cost-effectiveness analyses indicate that opt-out chlamydia screening among adolescent and young adult females might substantially increase screening, be cost saving and identify infections among patients who do not disclose sexual behavior.
Nationwide Children’s has provided sample opt-out letters that providers may download and customize for patient/parent communication:
Patient Letter (Customizable)
Download:
- English
- Spanish
Parent Letter (Customizable)
